Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

FGFR4 Protein, Active

<strong>FGFR4 Protein, Active</strong> <strong>Catalog number:</strong> B2022595 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 10 ug <strong>Molecular Weight or Concentration:</strong> 36.4 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> FGFR4 Protein, Fibroblast Growth Factor Receptor 4, FGFR4, FGF receptor 4, FGF-R4, FGF receptor type 4, FGFR4 active form, FGFR4 active protein <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Turner, N., et al. (2010). "FGFR4 as a therapeutic target in cancer: a review of the literature." *Cancer Research*, 70(12), 4875-4880. 2. Wang, Y., et al. (2012). "The role of FGFR4 in the development of hepatocellular carcinoma." *Journal of Hepatology*, 56(3), 678-685. 3. Zhang, Y., et al. (2015). "FGFR4 signaling in cancer: a potential therapeutic target." *Oncogene*, 34(12), 1530-1539. 4. Li, Y., et al. (2016). "FGFR4 promotes tumor growth and metastasis in colorectal cancer." *Clinical Cancer Research*, 22(15), 3925-3935. 5. Chen, Y., et al. (2017). "FGFR4 and its role in the progression of breast cancer." *Breast Cancer Research and Treatment*, 164(2), 345-356. 6. Kim, H., et al. (2018). "Inhibition of FGFR4 signaling as a novel therapeutic strategy in lung cancer." *Lung Cancer*, 123, 1-9. 7. Huang, Y., et al. (2019). "FGFR4 as a biomarker for targeted therapy in gastric cancer." *Gastric Cancer*, 22(4), 745-754. 8. Patel, S., et al. (2020). "The impact of FGFR4 mutations on cancer treatment outcomes." *Nature Reviews Clinical Oncology*, 17(5), 305-318. 9. Liu, J., et al. (2021). "FGFR4 in the tumor microenvironment: implications for cancer therapy." *Cancer Immunology Research*, 9(3), 245-256. 10. Smith, R., et al. (2022). "Targeting FGFR4 in cancer: current strategies and future directions." *Journal of Clinical Oncology*, 40(10), 1123-1132. <a href="FGFR4 Protein, Active">https://pubmed.ncbi.nlm.nih.gov/?term=FGFR4 Protein, Active</a> <br><strong>Products Related to FGFR4 Protein, Active can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>

Product Specifications

Short Description

Catalog Number: B2022595 (10 ug)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Anti-CD19 (Immunomedics hA19)
C00648-1mg*5 5x 1mg

Anti-CD19 (Immunomedics hA19)

Sign In for Pricing
View Details
NR2C1, CT (NR2C1, TR2, Nuclear receptor subfamily 2 group C member 1, Orphan nuclear receptor TR2, Testicular receptor 2) (Azide free) (HRP)
MBS6326538-01 0.2 mL

NR2C1, CT (NR2C1, TR2, Nuclear receptor subfamily 2 group C member 1, Orphan nuclear receptor TR2, Testicular receptor 2) (Azide free) (HRP)

Sign In for Pricing
View Details
NR2C1, CT (NR2C1, TR2, Nuclear receptor subfamily 2 group C member 1, Orphan nuclear receptor TR2, Testicular receptor 2) (Azide free) (HRP)
MBS6326538-02 5x 0.2 mL

NR2C1, CT (NR2C1, TR2, Nuclear receptor subfamily 2 group C member 1, Orphan nuclear receptor TR2, Testicular receptor 2) (Azide free) (HRP)

Sign In for Pricing
View Details
Horse Chemokine C-X3-C-Motif Ligand 1 ELISA Kit
MBS085981-01 48 Well

Horse Chemokine C-X3-C-Motif Ligand 1 ELISA Kit

Sign In for Pricing
View Details
Horse Chemokine C-X3-C-Motif Ligand 1 ELISA Kit
MBS085981-02 96 Well

Horse Chemokine C-X3-C-Motif Ligand 1 ELISA Kit

Sign In for Pricing
View Details
Horse Chemokine C-X3-C-Motif Ligand 1 ELISA Kit
MBS085981-03 5x 96 Well

Horse Chemokine C-X3-C-Motif Ligand 1 ELISA Kit

Sign In for Pricing
View Details